COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business ...
Blue Star Gold Corp. (TSXV: BAU) (OTCQB: BAUFF) (FSE: 5WP0) ("Blue Star" or the "Company") announces initial results from its 2026 Exploration Program - Phase 2 drilling at the Nutaaq (North) target.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results